Literature DB >> 19681951

Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.

C Charlier1, V Enouf, F Lanternier, M Grandadam, K Amazzough, S Blanche, M Lecuit, O Lortholary, S van der Werf.   

Abstract

We describe a patient with confirmed novel H1N1 (swine-like) influenza A virus who had daily nasal swabs tested during oseltamivir therapy. Nasal shedding remained positive for 2 days and became negative on day 3. This report presents the first available data on the kinetics of shedding of this novel virus under antiviral therapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19681951     DOI： 10.1111/j.1469-0691.2009.03007.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  3 in total

1.  Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.

Authors:  Elena A Govorkova; Bindumadhav M Marathe; Ashley Prevost; Jerold E Rehg; Robert G Webster
Journal:  Antiviral Res       Date:  2011-05-27       Impact factor: 5.970

2.  Low attack rate of novel influenza A (H1N1) virus infection among healthcare workers: a prospective study in a setting with an elaborated containment plan.

Authors:  Patrick M Smit; Jan W Mulder; Mohamed Ahdi; Ron Gerritsen; Stanley Darma; Paul H M Smits; Chris Roggeveen; Eric C M van Gorp; Guus F Rimmelzwaan; Dees P M Brandjes
Journal:  Int Arch Occup Environ Health       Date:  2011-06-04       Impact factor: 3.015

Review 3.  Swine Influenza (H1N1) pneumonia: clinical considerations.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2010-03       Impact factor: 5.982
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.